S
|
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED ActiveScientific & Education |
Financial statements of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
According to SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED latest financial report submitted on 2021-03-31, the company has a Turnover of £10M, Total-Assets of £225M while the Working-Capital is £190M. Compared with the previous year, the company reported a Turnover decrease of -483.59%, which is an equivalent of 47.8 million. At the same time, the Total-Assets went up by 0.77%, or by -1746000.
Turnover 2021
£ 9.9 million
-
Consolidated A/cs
N
-
Reporting period
12
-
Working Capital
£ 190.1 million
-
Profit after Tax
£ 2.8 million
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED Business Credit Report
A Business Credit Report for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED Directors and key executives
View all employeesSHIRE PHARMACEUTICAL DEVELOPMENT LIMITED currently employs 5 people. Compared with the previous year, the company has reported a staff decrease of 92%, which is an equivalent of 59 employees. In order to view contact information, including emails and phone numbers for all the employees working at SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.
Total Employee Count
Total employees
5
8%
1y growth
125%
2y growth
Management Level
Middle
Employee | Job Title | Phone | Country | |
---|---|---|---|---|
Mark Gibbons | Director |
-
|
- | GB |
Marc Page | Director |
-
|
- | GB |
Kentaro Shirahata | Director |
-
|
- | GB |
Peter Grubin | Director |
-
|
- | GB |
Get in touch with 4 of contacts working at SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
Upgrade to subscriptionSHIRE PHARMACEUTICAL DEVELOPMENT LIMITED Ownership and Group Structure
View full group structureSHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is a subsidiary of SHIRE PHARMACE************* which holding company is TAKEDA PHARMACEUT****************, with the following registration number 02486738. The holding group consists of a total of 63 companies, including SHIRE INTELLECTUAL PRO*********************, SHIRE HOLDINGS IREL*****************, NPS PHARMA INTERN***************, SHIRE PHARMACEUTICAL INVESTM***************************, SHIRE IRELAND P*************.
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED competitors:
View all competitorsTop 5 similar companies of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED are INNOVATIVE TECHNOLOGY LIMITED, SAC COMMERCIAL LIMITED, TOSHIBA EUROPE LIMITED, GAFFNEY, CLINE & ASSOCIATES LIMITED, MUNDIPHARMA RESEARCH LIMITED. View and export all the competitor list of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED by upgrading your account here.
INNOVATIVE TECHNOLOGY LIMITED
SAC COMMERCIAL LIMITED
TOSHIBA EUROPE LIMITED
GAFFNEY, CLINE & ASSOCIATES LIMITED
MUNDIPHARMA RESEARCH LIMITED
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED news & activities:
View full activityTurnover
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED has submitted new account statements and has reported a turnover of £10M, a -483.59% increase year-over-year.
uk.globaldatabase.com
2021-03-31
EBITDA
The SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED-based company said the adjusted EBITDA is now £300,000.00, compared with the previous year of -2478000.
uk.globaldatabase.com
2021-03-31
Employees
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED number of employees has decreased by -92% compared with previous year and now represents a total number of 5.
uk.globaldatabase.com
2021-03-31
Frequently Asked Questions regarding SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
Where is SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED registered office?
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is located at 1 KINGDOM STREET LONDON, United Kingdom.
What is the website of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED?
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED website is http://shire.com
How many people work at SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED?
According to the latest account statement, there are currently 5 of employees working for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED.
How much revenue does SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED make?
Based on the latest financial accounts submitted on 2021-03-31, the company made £10M for 2021, which went down by -483.59%.
What is SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED EBITDA?
For 2021, SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED has reported an EBITDA of £300,000.00, which went down by -926.0% compared to previous year.
What is the Business Credit Score of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED and how reliable is the company?
In order to check the business credit score of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.
Does SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED pay their invoices on time?
By requesting a Business Credit Report for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED, you will be able to gain more insights about the SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED payment trends.
Who is the Ultimate Parent of the SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED?
Information about the ultimate beneficial ownership TAKEDA PHARMACEUT**************** of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is available when you order a business credit report.
Search for International Credit Report
Select your package
Name
|
City
|
Address
|
Reg. No
|
Status
|
Action |
---|
Select your package